Yu Cheng

Also affiliated with China Pharmaceutical University, Sichuan University, West China Hospital of Sichuan University, Changchun University of Chinese Medicine, First Hospital of China Medical University, Zigong First People's Hospital, Union Hospital, China Medical University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer”.

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02206-x

N/A

0.327DataRank · unranked

6 citations

Chunxiao Liu, Meisi Yan, Cong Chen, Yu Cheng, Yaohui Chen +20 more